BeiGene Net Income
| ONC Stock | 346.07 0.35 0.10% |
As of the 17th of February 2026, BeiGene shows the Downside Deviation of 1.83, mean deviation of 1.79, and Risk Adjusted Performance of 0.0412. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of BeiGene, as well as the relationship between them.
BeiGene Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.4336 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -580.3 M | -609.3 M | |
| Net Loss | -741.5 M | -778.6 M | |
| Net Loss | (7.04) | (7.39) | |
| Net Income Per E B T | 1.09 | 0.82 |
BeiGene | Net Income | Build AI portfolio with BeiGene Stock |
Analyzing BeiGene's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing BeiGene's current valuation and future prospects.
Latest BeiGene's Net Income Growth Pattern
Below is the plot of the Net Income of BeiGene over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BeiGene financial statement analysis. It represents the amount of money remaining after all of BeiGene operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BeiGene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (644.79 M) | 10 Years Trend |
|
Net Income |
| Timeline |
BeiGene Net Income Regression Statistics
| Arithmetic Mean | (573,106,128) | |
| Coefficient Of Variation | (111.04) | |
| Mean Deviation | 502,020,120 | |
| Median | (580,307,400) | |
| Standard Deviation | 636,353,431 | |
| Sample Variance | 404945.7T | |
| Range | 2B | |
| R-Value | (0.64) | |
| Mean Square Error | 253672.1T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | (80,957,042) | |
| Total Sum of Squares | 6479131T |
BeiGene Net Income History
Other Fundumenentals of BeiGene
BeiGene Net Income component correlations
BeiGene Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for BeiGene is extremely important. It helps to project a fair market value of BeiGene Stock properly, considering its historical fundamentals such as Net Income. Since BeiGene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BeiGene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BeiGene's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could BeiGene diversify its offerings? Factors like these will boost the valuation of BeiGene. Anticipated expansion of BeiGene directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BeiGene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.52 | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
Understanding BeiGene requires distinguishing between market price and book value, where the latter reflects BeiGene's accounting equity. The concept of intrinsic value - what BeiGene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push BeiGene's price substantially above or below its fundamental value.
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, BeiGene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
BeiGene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BeiGene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BeiGene.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in BeiGene on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding BeiGene or generate 0.0% return on investment in BeiGene over 90 days. BeiGene is related to or competes with Humana, Insmed, GE HealthCare, ResMed, IQVIA Holdings, Alcon AG, and Mettler Toledo. BeiGene is entity of United States. It is traded as Stock on NASDAQ exchange. More
BeiGene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BeiGene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BeiGene upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.83 | |||
| Information Ratio | 0.0142 | |||
| Maximum Drawdown | 14.16 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 4.39 |
BeiGene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BeiGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BeiGene's standard deviation. In reality, there are many statistical measures that can use BeiGene historical prices to predict the future BeiGene's volatility.| Risk Adjusted Performance | 0.0412 | |||
| Jensen Alpha | 0.0454 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.019 | |||
| Treynor Ratio | 0.1151 |
BeiGene February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0412 | |||
| Market Risk Adjusted Performance | 0.1251 | |||
| Mean Deviation | 1.79 | |||
| Semi Deviation | 1.73 | |||
| Downside Deviation | 1.83 | |||
| Coefficient Of Variation | 2338.48 | |||
| Standard Deviation | 2.45 | |||
| Variance | 6.0 | |||
| Information Ratio | 0.0142 | |||
| Jensen Alpha | 0.0454 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.019 | |||
| Treynor Ratio | 0.1151 | |||
| Maximum Drawdown | 14.16 | |||
| Value At Risk | (2.78) | |||
| Potential Upside | 4.39 | |||
| Downside Variance | 3.36 | |||
| Semi Variance | 3.0 | |||
| Expected Short fall | (2.37) | |||
| Skewness | 1.24 | |||
| Kurtosis | 2.92 |
BeiGene Backtested Returns
BeiGene secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. BeiGene exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BeiGene's Downside Deviation of 1.83, risk adjusted performance of 0.0412, and Mean Deviation of 1.79 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BeiGene's returns are expected to increase less than the market. However, during the bear market, the loss of holding BeiGene is expected to be smaller as well. At this point, BeiGene has a negative expected return of -0.0169%. Please make sure to confirm BeiGene's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if BeiGene performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
BeiGene has very good reverse predictability. Overlapping area represents the amount of predictability between BeiGene time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BeiGene price movement. The serial correlation of -0.69 indicates that around 69.0% of current BeiGene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 85.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
BeiGene Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, BeiGene reported net income of (644.79 Million). This is 288.93% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.
BeiGene Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in net income category among its peers.
BeiGene Current Valuation Drivers
We derive many important indicators used in calculating different scores of BeiGene from analyzing BeiGene's financial statements. These drivers represent accounts that assess BeiGene's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BeiGene's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.1B | 2.0B | 2.0B | 2.3B | 2.1B | 2.2B | |
| Enterprise Value | (1.6B) | (1.3B) | (191.8M) | 774.4M | 890.6M | 935.1M |
BeiGene ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BeiGene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BeiGene's managers, analysts, and investors.Environmental | Governance | Social |
BeiGene Fundamentals
| Return On Equity | 0.0181 | ||||
| Return On Asset | 0.0169 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 36.96 B | ||||
| Shares Outstanding | 101.81 M | ||||
| Shares Owned By Insiders | 17.30 % | ||||
| Shares Owned By Institutions | 31.37 % | ||||
| Number Of Shares Shorted | 1.39 M | ||||
| Price To Book | 9.27 X | ||||
| Price To Sales | 7.70 X | ||||
| Revenue | 3.81 B | ||||
| Gross Profit | 4.29 B | ||||
| EBITDA | (396.44 M) | ||||
| Net Income | (644.79 M) | ||||
| Total Debt | 1.08 B | ||||
| Book Value Per Share | 37.33 X | ||||
| Cash Flow From Operations | (140.63 M) | ||||
| Short Ratio | 4.69 X | ||||
| Earnings Per Share | 0.52 X | ||||
| Target Price | 409.21 | ||||
| Number Of Employees | 11 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 38.3 B | ||||
| Total Asset | 5.92 B | ||||
| Retained Earnings | (8.61 B) | ||||
| Working Capital | 1.78 B | ||||
| Net Asset | 5.92 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:Check out For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Biotechnology sector continue expanding? Could BeiGene diversify its offerings? Factors like these will boost the valuation of BeiGene. Anticipated expansion of BeiGene directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BeiGene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.52 | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
Understanding BeiGene requires distinguishing between market price and book value, where the latter reflects BeiGene's accounting equity. The concept of intrinsic value - what BeiGene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push BeiGene's price substantially above or below its fundamental value.
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, BeiGene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.